Boston Food Biotech Gets €38M from Nestlé

25/02/2016 - 3 minutes

Pronutria (US) is a start-up out of Flagship Ventures developing nutritional therapies which has now gotten a huge equity investment from Nestlé Health Science (Switzerland).

pronutria_biosciences_food_therapeutics_muscle_loss_amino_acids_protein_nestle_healthPronutria is a cool Biotech start-up taking an innovative approach to treat diseases caused by amino acid imbalance, such as muscle loss, and neurological and liver complications.

Besides being essential for protein synthesis, amino acids also play an important role in cell homeostasis and regulating health. And when this system fails, it can cause up to 2,000 different diseases…

Pronutria’s solution combines a Systems Biology (an important research field) understanding of the human metabolism, with its own library of the food proteome. With this, it managed to create algorithms that can suggest the ideal protein to use as therapy for a range of metabolic diseases.

The concept has now attracted Nestlé Health Sciences, which joins the list of Pronutria’s partners with an equity investment of about €38M ($42.5M).

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
Do you want to remove this advert? Become a member!
Do you want to remove this advert? Become a member!